• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切除术治疗弥漫性糖尿病性黄斑水肿的有效性可能取决于其术前光学相干断层扫描图像特征。

The effectiveness of vitrectomy for diffuse diabetic macular edema may depend on its preoperative optical coherence tomography pattern.

作者信息

Ichiyama Yusuke, Sawada Osamu, Mori Takamasa, Fujikawa Masato, Kawamura Hajime, Ohji Masahito

机构信息

Department of Ophthalmology, Shiga University of Medical Science, Seta Tsukinowacho, Otsu, Shiga, 520-2192, Japan.

Soseikai General Hospital, Kyoto, 612-8473, Japan.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1545-1551. doi: 10.1007/s00417-015-3251-4. Epub 2016 Jan 18.

DOI:10.1007/s00417-015-3251-4
PMID:26780461
Abstract

BACKGROUND

To investigate the effectiveness of vitrectomy for diffuse diabetic macular edema (DDME) and its dependence on optical coherence tomography (OCT) findings.

METHODS

The records of 65 patients and 81 eyes who received vitrectomy for DDME and followed up for at least 6 months were retrospectively reviewed. All eyes were classified according to their morphological characteristics on OCT including sponge-like diffuse retinal thickening (SDRT: n = 13), cystoid macular edema (CME: n = 42), serous retinal detachment (SRD: n = 13), and the combination of all morphological characteristics (FULL: n = 13). The best-corrected visual acuity (BCVA) and spectral domain OCT were investigated preoperatively and at 1, 3, and 6 months postoperatively.

RESULTS

At six months after surgery, BCVA in logMAR units was significantly improved in all groups except the SDRT group. The improvement was -0.04 ± 0.20 in the SDRT group (P = 0.504), -0.16 ± 0.24 in the CME group (P < 0.01), -0.32 ± 0.32 in the SRD group (P < 0.01), and -0.26 ± 0.19 in the FULL group (P < 0.01), and significantly better in eyes with subretinal fluid (SRF; the SRD and FULL groups) than in eyes without SRF (the SDRT and CME groups, P = 0.003).

CONCLUSIONS

Vitrectomy can be a useful treatment option for DDME, particularly for eyes with SRF.

摘要

背景

探讨玻璃体切除术治疗弥漫性糖尿病性黄斑水肿(DDME)的有效性及其对光学相干断层扫描(OCT)结果的依赖性。

方法

回顾性分析65例患者81只接受DDME玻璃体切除术并随访至少6个月的病例记录。根据OCT上的形态学特征将所有眼睛分类,包括海绵状弥漫性视网膜增厚(SDRT:n = 13)、黄斑囊样水肿(CME:n = 42)、浆液性视网膜脱离(SRD:n = 13)以及所有形态学特征的组合(FULL:n = 13)。术前及术后1、3和6个月检查最佳矫正视力(BCVA)和光谱域OCT。

结果

术后6个月,除SDRT组外,所有组的logMAR单位BCVA均有显著改善。SDRT组改善为-0.04±0.20(P = 0.504),CME组为-0.16±0.24(P < 0.01),SRD组为-0.32±0.32(P < 0.01),FULL组为-0.26± 0.19(P < 0.01),有视网膜下液(SRF;SRD组和FULL组)的眼睛比无SRF的眼睛(SDRT组和CME组)改善明显更好(P = 0.003)。

结论

玻璃体切除术可能是DDME的一种有效治疗选择,特别是对于有SRF的眼睛。

相似文献

1
The effectiveness of vitrectomy for diffuse diabetic macular edema may depend on its preoperative optical coherence tomography pattern.玻璃体切除术治疗弥漫性糖尿病性黄斑水肿的有效性可能取决于其术前光学相干断层扫描图像特征。
Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1545-1551. doi: 10.1007/s00417-015-3251-4. Epub 2016 Jan 18.
2
Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema.弥漫性糖尿病性黄斑水肿患者玻璃体内曲安奈德的视觉结果取决于光相干断层扫描模式。
Retina. 2011 Apr;31(4):748-54. doi: 10.1097/IAE.0b013e3181f04991.
3
Structural Changes of the Macula on Optical Coherence Tomography after Vitrectomy for Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变玻璃体切除术后黄斑区光学相干断层扫描的结构变化
Ophthalmologica. 2017;238(4):186-195. doi: 10.1159/000477826. Epub 2017 Jul 21.
4
Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema.弥漫性糖尿病黄斑水肿患者的光学相干断层扫描模式对玻璃体内注射贝伐单抗的视力结果有影响。
Retina. 2013 Apr;33(4):740-7. doi: 10.1097/IAE.0b013e31826b6763.
5
Optical coherence tomographic assessment of macular thickness and morphological patterns in diabetic macular edema: prognosis after modified grid photocoagulation.光学相干断层扫描评估糖尿病性黄斑水肿的黄斑厚度和形态学模式:改良格栅光凝后的预后
Nepal J Ophthalmol. 2012 Jan-Jun;4(1):128-33. doi: 10.3126/nepjoph.v4i1.5864.
6
Vitrectomy in the management of diabetic macular edema in treatment-naïve patients.玻璃体切除术治疗未经治疗的糖尿病黄斑水肿。
Can J Ophthalmol. 2018 Aug;53(4):402-407. doi: 10.1016/j.jcjo.2017.10.011. Epub 2017 Dec 23.
7
Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.玻璃体内注射雷珠单抗治疗伴有浆液性视网膜脱离的糖尿病性黄斑水肿的疗效
Korean J Ophthalmol. 2018 Aug;32(4):296-302. doi: 10.3341/kjo.2017.0117.
8
Vitrectomy for Diabetic Macular Edema: Optical Coherence Tomography Criteria and Pathology of the Vitreomacular Interface.玻璃体切割术治疗糖尿病性黄斑水肿:光学相干断层扫描标准和玻璃体黄斑界面的病理学。
Am J Ophthalmol. 2019 Apr;200:34-46. doi: 10.1016/j.ajo.2018.12.004. Epub 2018 Dec 14.
9
Tomographic assessment of vitreous surgery for diabetic macular edema.糖尿病性黄斑水肿玻璃体手术的断层扫描评估
Am J Ophthalmol. 2000 Apr;129(4):487-94. doi: 10.1016/s0002-9394(99)00409-2.
10
Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.光学相干断层扫描在评估玻璃体切割术前和术后糖尿病性黄斑水肿中的应用
Am J Ophthalmol. 2003 Feb;135(2):169-77. doi: 10.1016/s0002-9394(02)01837-8.

引用本文的文献

1
Diabetic retinopathy: emerging concepts of current and potential therapy.糖尿病视网膜病变:当前及潜在治疗的新观念
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3395-3406. doi: 10.1007/s00210-023-02599-y. Epub 2023 Jul 4.
2
Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.玻璃体切除术在非牵引性难治性糖尿病性黄斑水肿中的作用
J Clin Med. 2023 Mar 15;12(6):2297. doi: 10.3390/jcm12062297.
3
Vitrectomy in Diabetic Macular Edema:: A Swept-source OCT Angiography Study.糖尿病性黄斑水肿的玻璃体切除术:一项扫频光学相干断层扫描血管造影研究

本文引用的文献

1
Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema.弥漫性糖尿病黄斑水肿患者的光学相干断层扫描模式对玻璃体内注射贝伐单抗的视力结果有影响。
Retina. 2013 Apr;33(4):740-7. doi: 10.1097/IAE.0b013e31826b6763.
2
Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys.玻璃体切割术对食蟹猴房水中 VEGF 浓度和贝伐珠单抗药代动力学的影响。
Invest Ophthalmol Vis Sci. 2012 Aug 24;53(9):5877-80. doi: 10.1167/iovs.12-10164.
3
Diabetic retinopathy.
Ophthalmol Sci. 2022 Aug 9;2(4):100207. doi: 10.1016/j.xops.2022.100207. eCollection 2022 Dec.
4
Diabetic macular edema treatment guidelines in India: All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement.印度糖尿病性黄斑水肿治疗指南:全印度眼科协会糖尿病视网膜病变工作组和印度玻璃体视网膜学会共识声明。
Indian J Ophthalmol. 2021 Nov;69(11):3076-3086. doi: 10.4103/ijo.IJO_1469_21.
5
Vitrectomy for diabetic macular edema and the relevance of external limiting membrane.玻璃体切割术治疗糖尿病性黄斑水肿及外界膜的相关性。
BMC Ophthalmol. 2021 Sep 15;21(1):334. doi: 10.1186/s12886-021-02095-y.
6
Optical Coherence Tomography (Angiography) Biomarkers in the Assessment and Monitoring of Diabetic Macular Edema.光学相干断层扫描(血管造影)生物标志物在糖尿病性黄斑水肿评估和监测中的应用。
J Diabetes Res. 2020 Dec 31;2020:6655021. doi: 10.1155/2020/6655021. eCollection 2020.
7
Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema.糖尿病视网膜病变和糖尿病性黄斑水肿中的新型成像生物标志物。
Ther Adv Ophthalmol. 2020 Sep 4;12:2515841420950513. doi: 10.1177/2515841420950513. eCollection 2020 Jan-Dec.
8
The Area and Number of Intraretinal Cystoid Spaces Predict the Visual Outcome after Ranibizumab Monotherapy in Diabetic Macular Edema.视网膜内囊样间隙的面积和数量可预测糖尿病性黄斑水肿患者接受雷珠单抗单药治疗后的视力预后。
J Clin Med. 2020 May 8;9(5):1391. doi: 10.3390/jcm9051391.
9
The Evolving Treatment of Diabetic Retinopathy.糖尿病视网膜病变的治疗进展
Clin Ophthalmol. 2020 Mar 4;14:653-678. doi: 10.2147/OPTH.S236637. eCollection 2020.
10
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment.在药物治疗时代重新审视玻璃体切割术在糖尿病性黄斑水肿初始治疗中的应用
Taiwan J Ophthalmol. 2019 Dec 13;9(4):224-232. doi: 10.4103/tjo.tjo_61_19. eCollection 2019 Oct-Dec.
糖尿病视网膜病变
N Engl J Med. 2012 Mar 29;366(13):1227-39. doi: 10.1056/NEJMra1005073.
4
Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema.弥漫性糖尿病性黄斑水肿患者玻璃体内曲安奈德的视觉结果取决于光相干断层扫描模式。
Retina. 2011 Apr;31(4):748-54. doi: 10.1097/IAE.0b013e3181f04991.
5
Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.曲安奈德与贝伐单抗玻璃体内注射治疗糖尿病黄斑水肿后房水中各种细胞因子浓度的变化。
Am J Ophthalmol. 2011 Oct;152(4):686-94. doi: 10.1016/j.ajo.2011.03.033. Epub 2011 Jul 22.
6
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.糖尿病性黄斑水肿和玻璃体视网膜牵引的玻璃体切割术结果。
Ophthalmology. 2010 Jun;117(6):1087-1093.e3. doi: 10.1016/j.ophtha.2009.10.040. Epub 2010 Mar 17.
7
Vitreous VEGF clearance is increased after vitrectomy.玻璃体 VEGF 清除率在玻璃体切除术后增加。
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2135-8. doi: 10.1167/iovs.09-3582. Epub 2009 Dec 17.
8
Diabetic macular edema: pathogenesis and treatment.糖尿病性黄斑水肿:发病机制与治疗
Surv Ophthalmol. 2009 Jan-Feb;54(1):1-32. doi: 10.1016/j.survophthal.2008.10.001.
9
Vascular endothelial growth factor and diabetic complications.血管内皮生长因子与糖尿病并发症
Prog Retin Eye Res. 2008 Nov;27(6):608-21. doi: 10.1016/j.preteyeres.2008.09.002. Epub 2008 Oct 1.
10
Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels.地塞米松通过刺激钠钾ATP酶和上皮钠通道的活性及表达,防止大鼠肺和肺泡上皮细胞因缺氧而出现转运抑制。
Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1332-8. doi: 10.1152/ajplung.00338.2006. Epub 2007 Sep 14.